WHO Expert Committee on Biological Standardization : sixty-third report. /
Spremljeno u:
| Autor kompanije: | |
|---|---|
| Format: | Elektronički e-knjiga |
| Jezik: | engleski |
| Izdano: |
Geneva, Switzerland :
World Health Organization,
2014.
|
| Serija: | Technical report series (World Health Organization) ;
980. |
| Teme: | |
| Online pristup: | An electronic book accessible through the World Wide Web; click to view |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
Slični predmeti
WHO Expert Committee on Biological Standardization : sixty-third report. /
Izdano: (2014)
Izdano: (2014)
Who Expert Committee on Biological Standardization : sixty-second report.
Izdano: (2013)
Izdano: (2013)
Who Expert Committee on Biological Standardization : sixty-second report.
Izdano: (2013)
Izdano: (2013)
WHO Expert Committee on Biological Standardization : sixtieth report /
Izdano: (2013)
Izdano: (2013)
WHO Expert Committee on Biological Standardization : sixtieth report /
Izdano: (2013)
Izdano: (2013)
WHO Expert Committee on Biological Standardization fifty-sixth report.
Izdano: (2007)
Izdano: (2007)
WHO Expert Committee on Biological Standardization fifty-sixth report.
Izdano: (2007)
Izdano: (2007)
WHO Expert Committee on Biological Standardization : sixty-first report.
Izdano: (2013)
Izdano: (2013)
WHO Expert Committee on Biological Standardization : sixty-first report.
Izdano: (2013)
Izdano: (2013)
WHO Expert Committee on Biological Standardization fifty-second report.
Izdano: (2004)
Izdano: (2004)
WHO Expert Committee on Biological Standardization fifty-fourth report.
Izdano: (2005)
Izdano: (2005)
WHO Expert Committee on Biological Standardization fifty-fourth report.
Izdano: (2005)
Izdano: (2005)
WHO Expert Committee on Biological Standardization fifty-second report.
Izdano: (2004)
Izdano: (2004)
WHO Expert Committee on Specifications for Pharmaceutical Preparations forty-first report.
Izdano: (2007)
Izdano: (2007)
WHO Expert Committee on Specifications for Pharmaceutical Preparations forty-first report.
Izdano: (2007)
Izdano: (2007)
WHO Expert Committee on Specification for Pharmaceutical Preparations forty-second report.
Izdano: (2008)
Izdano: (2008)
WHO Expert Committee on Specification for Pharmaceutical Preparations forty-second report.
Izdano: (2008)
Izdano: (2008)
The selection and use of essential medicines
Izdano: (2006)
Izdano: (2006)
The selection and use of essential medicines
Izdano: (2006)
Izdano: (2006)
WHO Expert Committee on Specifications for Pharmaceutical Preparations : forty-eighth meeting report /
Izdano: (2014)
Izdano: (2014)
WHO Expert Committee on Specifications for Pharmaceutical Preparations : forty-eighth meeting report /
Izdano: (2014)
Izdano: (2014)
WHO Expert Committee on Specifications for Pharmaceutical Preparations fortieth report.
Izdano: (2006)
Izdano: (2006)
WHO Expert Committee on Specifications for Pharmaceutical Preparations fortieth report.
Izdano: (2006)
Izdano: (2006)
WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-ninth report.
Izdano: (2005)
Izdano: (2005)
WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-ninth report.
Izdano: (2005)
Izdano: (2005)
WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-seventh report.
Izdano: (2003)
Izdano: (2003)
WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-seventh report.
Izdano: (2003)
Izdano: (2003)
Good manufacturing practices for pharmaceuticals a plan for total quality control from manufacturer to consumer /
od: Willig, Sidney H., 1919-
Izdano: (2000)
od: Willig, Sidney H., 1919-
Izdano: (2000)
Good manufacturing practices for pharmaceuticals a plan for total quality control from manufacturer to consumer /
od: Willig, Sidney H., 1919-
Izdano: (2000)
od: Willig, Sidney H., 1919-
Izdano: (2000)
Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account /
od: Osmane, Malik
Izdano: (2014)
od: Osmane, Malik
Izdano: (2014)
Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account /
od: Osmane, Malik
Izdano: (2014)
od: Osmane, Malik
Izdano: (2014)
The selection and use of essential medicines report of the WHO Expert Committee, 2002.
Izdano: (2003)
Izdano: (2003)
The selection and use of essential medicines report of the WHO Expert Committee, 2002.
Izdano: (2003)
Izdano: (2003)
Standardization studies from the Germanic languages /
Izdano: (2002)
Izdano: (2002)
Standardization studies from the Germanic languages /
Izdano: (2002)
Izdano: (2002)
The selection and use of essential medicines report of the WHO Expert Committee, 2003 ; (including the 13th Model List of Essential Medicines).
Izdano: (2004)
Izdano: (2004)
The selection and use of essential medicines report of the WHO Expert Committee, 2003 ; (including the 13th Model List of Essential Medicines).
Izdano: (2004)
Izdano: (2004)
IFLA cataloguing principles steps towards an international cataloguing code, 3 : report from the 3rd IFLA Meeting of Experts on an International Cataloguing Code, Cairo, Egypt, 2005 /
Izdano: (2006)
Izdano: (2006)
IFLA cataloguing principles steps towards an international cataloguing code, 4 : report from the 4th IFLA Meeting of Experts on an International Cataloguing Code, Seoul, Korea, 2006 /
Izdano: (2007)
Izdano: (2007)
IFLA cataloguing principles steps towards an international cataloguing code, 4 : report from the 4th IFLA Meeting of Experts on an International Cataloguing Code, Seoul, Korea, 2006 /
Izdano: (2007)
Izdano: (2007)